Recent Articles from Business Wire

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and simultaneously published in the Journal of Clinical Oncology.

Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused on precision oncology therapeutics, today announced that the clinical data for Vebreltinib plus Andamertinib (PLB1004), its innovative combination of potent mesenchymal-epithelial transition factor (MET) inhibitor and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), has been presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025.

University of Phoenix honored its annual Faculty of the Year Award recipients at an awards ceremony event held Saturday, May 17, at the Royal Palms Resort in Phoenix, Arizona. The Faculty of the Year Award is part of the Faculty Rewards & Recognition Program at University of Phoenix (UOPX). Each year, the university announces a nomination period and asks students, employees and faculty to nominate UOPX faculty for the award. The awards ceremony was part of a series of weekend activities held to promote community and connection for faculty recipients.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of BioSig Technologies, Inc. (NasdaqCM: BSGM) and Streamex Exchange Corporation. Upon closing of the proposed transaction, current BioSig shareholders and holders of common stock equivalents will hold 25% of the fully diluted BioSig common stock outstanding. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to BioSig shareholders.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Heliogen, Inc. (OTC: HLGN) to Zeo Energy Corp. (NasdaqCM: ZEO). Under the terms of the proposed transaction, shareholders of Heliogen will receive shares of Zeo’s Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment mechanism based on Heliogen’s net cash at the closing. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Signing Day Sports, Inc. (NYSE: SGN) and One Blockchain LLC. Upon closing of the proposed transaction, Signing Day shareholders are expected to own approximately 8.5% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Signing Day shareholders.

The law firm of Robbins Geller Rudman & Dowd LLP announces that holders of Broadmark Realty Capital Inc. (NYSE: BRMK) common stock as of the record date of the May 2023 merger between Broadmark and Ready Capital Corporation (NYSE: RC) (“Merger”), have until July 28, 2025 to seek appointment as lead plaintiff of the Broadmark class action lawsuit. Captioned Grant v. Broadmark Realty Capital, No. 25-cv-01013 (W.D. Wash.), the Broadmark class action lawsuit charges Broadmark, Ready Capital, certain of Broadmark’s and Ready Capital’s top executives and directors, and Ready Capital’s external asset manager with violations of the Securities Exchange Act of 1934.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, both dates inclusive (the “Class Period”), have until July 28, 2025 to seek appointment as lead plaintiff of the UroGen class action lawsuit. Captioned Cockrell v. UroGen Pharma Ltd., 25-cv-06088 (D.N.J.), the UroGen class action lawsuit charges UroGen and certain of UroGen’s top current and former executives with violations of the Securities Exchange Act of 1934.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch of its Fuses program. This initiative will harness Tempus’ proprietary dataset to generate valuable insights for both patient care and research, combining the power of its data and machine learning capabilities to develop an AI enabled-diagnostic platform offering physicians the largest suite of algorithmic tests designed to make precision medicine a reality.

ispace, inc. (ispace) (TOKYO: 9348), a global lunar exploration company, announced today that the RESILIENCE lunar lander has successfully completed all orbital maneuvers while in lunar orbit and is now being prepared for its landing attempt on June 6, 2025.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and its research collaborators today presented results of the largest study to date evaluating circulating tumor DNA (ctDNA) in colon cancer prior to chemotherapy, demonstrating the ability of the Guardant Reveal™ test to stratify the risk of disease recurrence and overall survival, and thus inform treatment decisions after surgery. Data from the phase III trial of FOLFOX-based adjuvant chemotherapy (NCCTG N0147) involving over 2,000 patients with stage III colon cancer with median follow-up of 6.1 years were presented at the 2025 American Society for Clinical Oncology (ASCO) Annual Meeting.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ItovebiTM (inavolisib), in combination with palbociclib (Ibrance®) and fulvestrant, reduced the risk of death by more than 30% compared with palbociclib and fulvestrant alone. This represents a statistically significant and clinically meaningful improvement in overall survival for people with PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, endocrine-resistant, locally advanced or metastatic breast cancer. The results are being presented in an oral session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in the New England Journal of Medicine (NEJM).

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA® (pembrolizumab) plus Trodelvy® (sacituzumab govitecan-hziy) reduced the risk of disease progression or death by 35% (HR=0.65, p<0.001) versus KEYTRUDA plus chemotherapy for the first-line treatment of patients with PD-L1+ (Combined Positive Score [CPS] ≥10) inoperable (unresectable) locally advanced or metastatic triple-negative breast cancer (TNBC), as determined by an FDA-approved test. KEYTRUDA, when given in combination with Gilead’s TROP2 antibody-drug conjugate (ADC) Trodelvy, resulted in a median progression-free survival (PFS) of 11.2 months versus 7.8 months when KEYTRUDA was given in combination with chemotherapy. These data from the pivotal Phase 3 ASCENT-04/KEYNOTE-D19 study will be presented today as a late-breaking oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract #LBA109) and were selected for the official ASCO Press Program.

High school students who quickly answered tough questions posed to state-championship teams at the Council for Economic Education’s National Economics Challenge (NEC) finals may not change the world today.

Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and simultaneously published in the Journal of Clinical Oncology.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced Trodelvy® (sacituzumab govitecan-hziy) plus Keytruda® (pembrolizumab) reduced the risk of disease progression or death by 35% (HR: 0.65) versus standard of care Keytruda plus chemotherapy in first-line treatment for patients with PD-L1+ (CPS ≥10) metastatic triple-negative breast cancer (TNBC). Trodelvy when given in combination with Keytruda resulted in a median progression-free survival (PFS) of 11.2 months vs 7.8 months when Keytruda was given in combination with chemotherapy. These data from the pivotal Phase 3 ASCENT-04/KEYNOTE-D19 study will be presented today as a late-breaking oral presentation at the 2025 ASCO Annual Congress (Abstract #LBA109).

Positive results from the DESTINY-Gastric04 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to ramucirumab plus paclitaxel in patients with second-line HER2 positive (IHC 3+ or IHC 2+/ISH+) unresectable and/or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. Results will be presented today as a late-breaking oral presentation (LBA #4002) at the 2025 American Society of Clinical Oncology (#ASCO25) Annual Meeting and simultaneously published in The New England Journal of Medicine.

Mythic Therapeutics, a clinical-stage biotechnology company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, today presented updated data from its Phase 1 KisMET-01 study evaluating its investigational cMET-targeting ADC candidate, MYTX-011, in patients with previously treated, locally advanced or metastatic non-small cell lung cancer (NSCLC), in a poster at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. MYTX-011 is a novel ADC engineered with pH-dependent binding to more precisely deliver anti-tumor payload across a range of cMET expression levels, with the goal of reducing toxicity and expanding the number of patients who can benefit from ADC therapy.

ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced the integration of the American Society of Clinical Oncology® (ASCO®) Guidelines through the CARAai platform for its Precision Suite and CancerLinQ® SmartLinQ solutions™. Now, the power of the Precision Suite’s low-latency and high-recency data can be used by biopharma researchers to assess Guideline-concordant care and outcomes at any point in time or reviewing changes over time. Members of the CancerLinQ® network using SmartLinQ solutions will now have ASCO Guideline-concordant recommendations for their individual patients as an augmentation of their assessment of treatment options. This published information will be integrated with other SmartLinQ features that can help oncologists consider a complete set of treatment options for optimized patient outcomes.

Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that today the U.S. District Court for the District of Delaware (the “Court”) issued an order that further extended the Topping Period for submitting bids for the purchase of the shares of PDVH, the indirect holding company of Citgo Petroleum, to June 18, 2025. The order granted a motion by the Venezuela Parties (Citgo Petroleum, PDVH, PDVSA and the Republic of Venezuela) to extend the Topping Period, which motion was supported by Vitol, Inc., Rusoro Mining Ltd., the Company, and the Special Master appointed by the Court to oversee the sale process.

Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Statutory Basis Financial Statements Years Ended December 31, 2024 and 2023 With Report of Independent Auditors.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ: SATS) investors concerning the Company’s possible violations of the federal securities laws.

XTM Inc. (“XTM” or the “Company”) (QB: XTMIF / CSE: PAID / FSE: 7XT), a fintech innovator in automated tip calculations, instant payouts for employees and gig workers and a provider of Earned Wage Access (“EWA”) through its AnyDay™ platform, today announced it has filed its interim financial statements and management’s discussion and analysis (MD&A) for the quarter ended March 31, 2025 (the “Required Filings”).

KBRA assigns an issuer rating of BBB to The Fortegra Group, Inc. (TFG or Fortegra) and assigns an insurance financial strength rating (IFSR) of A- to Fortegra Specialty Insurance Company. At the same time, KBRA is affirming and withdrawing the BBB issuer rating for Fortegra Financial Corporation. In addition, KBRA affirms the A- IFSRs for the key U.S. insurance subsidiaries of The Fortegra Group, Inc.: Lyndon Southern Insurance Company; Insurance Company of the South; Response Indemnity Company of California; Life of the South Insurance Company; Southern Financial Life Insurance Company; and Bankers Life of Louisiana. Finally, KBRA also affirms the BBB- ratings of Fortegra's junior subordinated debt. The Outlook for all ratings is Stable. Fortegra is a leading provider of warranty and specialty underwriting products and services. The organization is headquartered in Jacksonville, Florida and is majority owned by Tiptree Inc. (NASDAQ: TIPT).

In an 8-K filing with the Securities and Exchange Commission on May 29, 2025, Sunnova Energy Corporation (Sunnova) disclosed that it had amended its Loan Guarantee Agreement with the U.S. Department of Energy (DOE) on May 22, 2025. The amendment reduced the maximum aggregate amount of partial guarantees from $3.0 billion to $371.6 million. This is equal to the total partial guarantees previously issued for Sunnova's two solar loan ABS transactions under Project Hestia: Sunnova Hestia I Issuer, LLC, Series 2023-GRID1 and Sunnova Hestia II Issuer, LLC, Series 2024-GRID1.

KBRA assigns an 'A-' rating to the Senior Loans, 'BBB-' rating to the Mezzanine Loans and 'B-' rating to the Junior Loans (together, the "Rated Loans") issued by Keys Investor II, LLC (the "Issuer" or "SPV") legally owned and controlled by Oceanview US Holdings ("OVUSH"). The outlook on each class of Rated Loans is 'Stable'. The total issuance amount, inclusive of the Subordinated Notes, is $150.0 million, with initial advance rates of 55.5%, 73.0% and 90.0% for the Senior Loans, Mezzanine Loans, and Junior Loans, respectively.

DoorDash, Inc. (NASDAQ: DASH) (“DoorDash”), a leading local commerce platform globally, today announced the closing of its previously announced private offering of $2.75 billion aggregate principal amount of its 0% convertible senior notes due 2030 (the “notes”). The notes were sold in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The offering represents the aggregate of both the previously announced, upsized offering of $2.5 billion, as well as the full exercise of the $250.0 million option to purchase additional notes granted by DoorDash to the initial purchasers of the notes.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ:URGN) securities during the period from July 27, 2023, through May 15, 2025 (“the Class Period”). Investors have until July 28, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Law Offices of Howard G. Smith continues its investigation on behalf of EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ: SATS) investors concerning the Company’s possible violations of federal securities laws.

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that Scott Richardson, President and Chief Executive Officer, will participate in a fireside discussion at the Deutsche Bank Global Industrials and Materials Conference on Thursday, June 5, 2025, at 11:50 AM Eastern Time.

Living up to the luster of its “Pearls of Wisdom” theme, the 2025 ACG Awards gala captivated a sell-out crowd of business luminaries across Orange County and the Inland Empire who came together to celebrate the top performing middle market companies in the region. The event, organized by the Association of Corporate Growth (ACG) Orange County Chapter, took place May 29, at the Irvine Marriott.

AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Nacional de Seguros S.A. Compañía de Seguros Generales (Nacional de Seguros) (Bogota, Colombia). The outlook of these Credit Ratings (ratings) is stable.

Priority Financial Group (PFG) proudly celebrates its 20th anniversary—marking two decades of delivering flexible, forward-thinking wealth management solutions to financial advisors and financial institutions nationally.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 3, 2025 to file lead plaintiff applications in a securities class action lawsuit against Viatris Inc. (“Viatris” or “the Company”) (NasdaqGS: VTRS), if they purchased the Company’s securities between August 8, 2024 and February 26, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Pennsylvania.

CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics and 3D digital twin technology in the property markets, announced today that CoStar Group and Happening Technology have concluded their dispute, with all parties withdrawing every claim with prejudice, bringing the matter to a final and amicable close.

Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”).

EDS Service Solutions, a national provider of labor outsourcing and workforce management services across the travel, hospitality, logistics, automotive and aviation industries, has been named a 2025 Georgia Fast 40 honoree by the Atlanta chapter of the Association for Corporate Growth.

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today announced that Sanjay Datta, Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley US Financials Conference on Tuesday, June 10 at 3:15pm ET (12:15pm PT).

Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) announced today its intention to redeem its issued and outstanding Cumulative Redeemable Floating Rate Reset Class A Preferred Shares, Series 19 ("Series 19 Shares") (TSX: PPL.PR.S) on June 30, 2025 (the "Redemption Date").

AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of “aa” (Superior) to the $1 billion, 6.17% surplus notes, due 2055, issued by The Northwestern Mutual Life Insurance Company (Northwestern Mutual) (Milwaukee, WI). The outlook assigned to this Credit Rating (rating) is stable.

The Law Offices of Frank R. Cruz continues its investigation of EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ: SATS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

AM Best has placed under review with developing implications the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of Insurance Corporation of Barbados Limited (ICBL) Barbados.

Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share:

Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4th, 2025 at 5:30 PM Eastern Time.

Karman Space & Defense (“Karman”, “Karman Holdings, Inc.” or “the Company”) (NYSE: KRMN), a leader in the rapid design, development and production of critical, next-generation system solutions for launch vehicle, satellite, spacecraft, missile defense, hypersonic and UAS customers, today announced that its Chief Executive Officer, Tony Koblinski, and Chief Financial Officer, Mike Willis, will present at the William Blair 45th Annual Growth Stock Conference on Thursday, June 5 at 11:20 a.m. Central Time.

Goldman Sachs Asset Management is announcing the final liquidating distribution of $0.291 per common share of the Goldman Sachs MLP and Energy Renaissance Fund (the “Fund”). Pursuant to the Fund’s Plan of Liquidation and Dissolution previously announced on June 7, 2023, shareholders of the Fund as of the close of business on July 10, 2023 will be entitled to receive the liquidating distribution. The liquidating distribution will be paid entirely in cash and will represent all of the Fund’s remaining assets after satisfying all liabilities and obligations of the Fund. Distribution proceeds are expected to be disbursed on June 3, 2025.

Corning Energy is pleased to announce that Tony Dorazio has been appointed Chief Executive Officer, effective June 2, 2025. Mr. Dorazio brings more than four decades of utility and energy industry experience. Throughout his career, he has led multiple organizations through complex industry transformations, while delivering value for stakeholders.

State Street Corporation (NYSE: STT) announced today that its Chairman & Chief Executive Officer, Ron O’Hanley, and its interim Chief Financial Officer, Mark Keating, will present at the Morgan Stanley U.S. Financials Conference in New York, NY on Wednesday, June 11, 2025 at approximately 9:00 am ET.

The Principal Real Estate Income Fund (NYSE:PGZ) announces the sources of a distribution paid on May 30, 2025 of $0.1050 per share to shareholders of record at the close of business on May 15, 2025, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission and includes the notice below sent to shareholders regarding the source of the distribution.

The Eaton Vance closed-end funds listed below released today the estimated sources of their May distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the May distribution. It is not determinative of the tax character of a Fund’s distributions for the 2025 calendar year. Shareholders should note that each Fund’s total regular distribution amount is subject to change as a result of market conditions or other factors.

The Real Brokerage Inc. (NASDAQ: REAX), a technology platform reshaping real estate for agents, home buyers, and sellers, today announced that its Board of Directors has authorized a new share repurchase program for up to the lesser of $150 million in value, or 35 million in shares.

Aviation Capital Group LLC (ACG), a premier global full-service aircraft asset manager, announced the delivery of one A321neo to Wizz Air. Powered by the ultra-efficient Pratt & Whitney GTF engines, this is the fourth aircraft scheduled to deliver to the airline as part of a multiple-aircraft sale-leaseback transaction between ACG and Wizz Air.

Coca-Cola Beverages Florida, LLC (Coke Florida) hosted the official grand opening of its new state-of-the-art Tampa Distribution Center and Fleet Facility yesterday, marking a major milestone of growth for the company in central Florida. The $300 million plus investment sits on the company’s 156-acre site, located at US 301 and the Selmon Expressway, and features a new 800,000 square foot, fully automated warehouse facility and a 250,000 square foot state-of-the-art fleet maintenance facility.

The Generation Essentials Group (“TGE”) and Black Spade Acquisition II Co (NASDAQ: BSII) (“Black Spade II”) today announced that their previously announced business combination (the “Business Combination”) was approved at an extraordinary general meeting of Black Spade II’s shareholders on May 30, 2025.

PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY) and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) declared today monthly distributions for June, July, and August 2025. The distribution amounts and schedule for each fund appears below:

Hayward Holdings, Inc. (NYSE: HAYW) (“Hayward” or the “Company”), a global designer, manufacturer, and marketer of a broad portfolio of pool equipment and outdoor living technology, announced today that it will be participating in the William Blair 45th Annual Growth Stock Conference in Chicago, Illinois, on Thursday, June 5, 2025.

CACI International Inc (NYSE: CACI) announced today that it has been awarded nearly $638 million in new contracts within the intelligence community to support various national security efforts.

Camden Property Trust (NYSE:CPT) (the “Company”) announced today it will participate in the Nareit REITweek 2025 Investor Conference on Tuesday, June 3 and Wednesday, June 4, 2025. The Company posted an updated Investor Presentation in conjunction with this event, which includes operating and transactions updates, and is available in the Investors section of the Company’s website.

Acadia Realty Trust (NYSE: AKR) (“Acadia” or the “Company”) today announced that it will participate in NAREIT’s REITweek®: 2025 Investor Conference.

Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or “the Company”), a global specialty insurer, announced today that Fidelis Insurance Bermuda Limited (“FIBL”) has successfully closed a new catastrophe bond through the issuance of the Series 2025-1 Class A Principal-at-Risk Variable Rate Notes (the “Series 2025-1 Notes”), by its Herbie Re Ltd. program (“Herbie Re”).

Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that, effective on May 7, 2025, the Compensation Committee of Energy Vault’s Board of Directors granted to 4 new, non-executive employees, restricted stock unit awards covering 481,000 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”). Out of 4 new, non-executive employees, the Compensation Committee granted a performance-based restricted stock unit award (the “PSU Award”) to 1 of them covering 400,000 shares of the Company’s common stock under the Inducement Award Plan. The restricted stock units and performance-based restricted stock units were granted as inducements material to the employees entering into employment with Energy Vault in accordance with New York Stock Exchange Listing Rule 303A.08.

CrowdStrike (NASDAQ: CRWD) today announced it has been named an innovation and growth Leader in the inaugural 2025 Frost Radar™: Cloud and Application Runtime Security, scoring highest of all vendors on the Innovation Index. Frost & Sullivan recognized CrowdStrike as the only CNAPP delivering unified, real-time protection across cloud, identity and endpoint – a core requirement for stopping cloud breaches as adversaries increasingly target modern hybrid environments.

First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.

VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq’s listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”).

Box (NYSE: BOX), the leading Intelligent Content Management (ICM) platform, today announced that members of its management team will present at the following conference:

TechTarget, Inc. (Nasdaq: TTGT) (“Informa TechTarget” or the “Company”) today announced that the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 27, 2025 notifying the Company that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), because the Company had not yet timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025 (the “Form 10-Q”) or, at the time of receipt of the Notice, its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”).

Duff & Phelps Utility and Infrastructure Fund Inc. (NYSE: DPG), a closed-end investment management company advised by Duff & Phelps Investment Management Co. (“Duff & Phelps”), today exercised an option to voluntarily redeem (“Redemption Date”) its remaining 1,400,000 issued and outstanding Floating Rate Mandatory Redeemable Preferred Shares, Series C (the “Series C MRP Shares”) (CUSIP No. 26433C4#9).

Mason Capital Management LLC (“Mason”), a registered investment advisor to funds and accounts holding approximately 3% of Grifols S.A. (“Grifols” or the “Company”) (BME: GRF) (NASDAQ: GRFS) class A shares, today announced that it sent a letter to the Grifols Board of Directors (the “Board”) expressing Mason’s support for the Company’s recommended slate of director candidates for election at the Ordinary General Shareholders’ Meeting to be held on June 4 and 5, 2025.

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (NYSE: RDDT) for potential violations of the federal securities laws.

Ernst & Young LLP (EY US) announced that Rod Larson, President and CEO of Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) has been named a finalist for the Entrepreneur Of The Year 2025 Gulf South Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the leaders of ground-breaking companies in industries that make a profound impact on communities. The Gulf South program celebrates entrepreneurs from Central and South Texas, Louisiana, and Mississippi.

POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the “Company” or “POSaBIT”), a leading provider of payments infrastructure in the cannabis industry, today announced its financial results for the three months ended March 31, 2025.

Coca-Cola Beverages Florida, LLC (Coke Florida) proudly celebrated its 10-year anniversary on May 29, 2025. This milestone represents a decade of the company’s growth, innovation, and commitment to local Florida communities.

Canada Goose Holdings Inc. (NYSE, TSX: GOOS) today announced that it will participate in the Baird 2025 Global Consumer, Technology and Services conference being held at the InterContinental New York Barclay in New York, NY on June 3, 2025. We will host a fireside chat presentation at 3:45 pm ET and participate in one-on-one meetings. Neil Bowden, Chief Financial Officer will attend the conference.